These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27122537)

  • 1. Activation of soluble guanylyl cyclase by BAY 58-2667 improves bladder function in cyclophosphamide-induced cystitis in mice.
    de Oliveira MG; Calmasini FB; Alexandre EC; De Nucci G; Mónica FZ; Antunes E
    Am J Physiol Renal Physiol; 2016 Jul; 311(1):F85-93. PubMed ID: 27122537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The soluble guanylyl cyclase activator BAY 60-2770 ameliorates overactive bladder in obese mice.
    Leiria LO; Silva FH; Davel AP; Alexandre EC; Calixto MC; De Nucci G; Mónica FZ; Antunes E
    J Urol; 2014 Feb; 191(2):539-47. PubMed ID: 24050894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitis.
    de Oliveira MG; Mónica FZ; Calmasini FB; Alexandre EC; Tavares EBG; Soares AG; Costa SKP; Antunes E
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F460-F468. PubMed ID: 29717937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
    Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
    J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats.
    Wróbel A; Doboszewska U; Rechberger E; Rojek K; Serefko A; Poleszak E; Skalicka-Woźniak K; Dudka J; Wlaź P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):613-619. PubMed ID: 28220212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
    Silva FH; Leiria LO; Alexandre EC; Davel AP; Mónica FZ; De Nucci G; Antunes E
    J Sex Med; 2014 Nov; 11(11):2661-70. PubMed ID: 25196910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with the soluble guanylate cyclase activator BAY 60-2770 normalizes bladder function in an in vivo rat model of chronic prostatitis.
    Aydogdu O; Perez F; Aronsson P; Uyar Gocun P; Carlsson T; Sandner P; Patel B; Winder M
    Eur J Pharmacol; 2022 Jul; 927():175052. PubMed ID: 35643304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model.
    Eser N; Göçmen C; Erdoğan S; Büyüknacar HS; Kumcu EK; Açıkalın A; Önder S
    Phytomedicine; 2012 Jun; 19(8-9):840-5. PubMed ID: 22647456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CYP-induced cystitis on PACAP/VIP and receptor expression in micturition pathways and bladder function in mice with overexpression of NGF in urothelium.
    Girard BM; Tompkins JD; Parsons RL; May V; Vizzard MA
    J Mol Neurosci; 2012 Nov; 48(3):730-43. PubMed ID: 22700375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soluble guanylyl cyclase activator BAY 60-2770 inhibits murine allergic airways inflammation and human eosinophil chemotaxis.
    Baldissera L; Squebola-Cola DM; Calixto MC; Lima-Barbosa AP; Rennó AL; Anhê GF; Condino-Neto A; De Nucci G; Antunes E
    Pulm Pharmacol Ther; 2016 Dec; 41():86-95. PubMed ID: 27816773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p75NTR in female rat urinary bladder with cyclophosphamide-induced cystitis.
    Klinger MB; Vizzard MA
    Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1778-89. PubMed ID: 18842820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor.
    Füllhase C; Hennenberg M; Sandner P; Strittmatter F; Niedworok C; Bauer RM; Gratzke C; Soler R; Stief C; Andersson KE
    Neurourol Urodyn; 2015 Nov; 34(8):787-93. PubMed ID: 25230878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor subtypes involved in urothelium-derived relaxatory effects in the inflamed rat urinary bladder.
    Andersson M; Aronsson P; Doufish D; Lampert A; Tobin G
    Auton Neurosci; 2012 Sep; 170(1-2):5-11. PubMed ID: 22789737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of the selective alpha1A-adrenoceptor antagonist silodosin against cyclophosphamide-induced cystitis in rats.
    Liu N; Shimizu S; Shimizu T; Nakamura K; Yamamoto M; Higashi Y; Saito M
    J Pharmacol Sci; 2016 Sep; 132(1):71-77. PubMed ID: 27654219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CYP-Induced Cystitis on Growth Factors and Associated Receptor Expression in Micturition Pathways in Mice with Chronic Overexpression of NGF in Urothelium.
    Girard BM; Malley S; May V; Vizzard MA
    J Mol Neurosci; 2016 Aug; 59(4):531-43. PubMed ID: 27259880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis.
    Ozawa H; Chancellor MB; Jung SY; Yokoyama T; Fraser MO; Yu Y; de Groat WC; Yoshimura N
    J Urol; 1999 Dec; 162(6):2211-6. PubMed ID: 10569621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of the putative P2X3/P2X2/3 antagonist A-317491 on cyclophosphamide-induced cystitis in rats.
    Ito K; Iwami A; Katsura H; Ikeda M
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):483-90. PubMed ID: 17917716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder.
    Juszczak K; Ziomber A; Wyczółkowski M; Thor PJ
    Can J Physiol Pharmacol; 2010 Sep; 88(9):899-906. PubMed ID: 20921976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
    Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
    Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional effects of blocking VEGF/VEGFR2 signaling in the rat urinary bladder in acute and chronic CYP-induced cystitis.
    Tooke K; Girard B; Vizzard MA
    Am J Physiol Renal Physiol; 2019 Jul; 317(7):F43-F51. PubMed ID: 30995112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.